Results 251 to 260 of about 5,756,266 (314)

Albumin-Based Biomarkers and Adverse Outcomes in Coronary Artery Disease: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Yang Y, Qu T, Zhang Y, Wan Z, Ge M.
europepmc   +1 more source

Investigation of Coronary Artery Disease

Journal of the Royal College of Physicians of London, 1986
openaire   +2 more sources

Incidence of Periprocedural Myocardial Injury and Infarction After Intravascular Lithotripsy for Calcified Coronary Artery Stenosis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular lithotripsy (IVL) has emerged as an effective technique for modifying heavily calcified coronary plaques, facilitating optimal stent expansion while minimizing procedural complications. However, data on periprocedural myocardial injury (PMI) and infarction (PPMI) following IVL remain scarce.
Gwaenaelle Aellen, Dorian Garin, Yannick Faucherre, Serban Puricel, Mario Togni, Stéphane Cook   +5 more
wiley   +1 more source

Antithrombotic Therapy in Primary and Secondary Prevention of Coronary Artery Disease. [PDF]

J Clin Med
Di Leo G, Spagnolo M, Giacoppo D, Greco A, Capodanno D.   +4 more
europepmc   +1 more source

Five‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer Drug‐Eluting Stents: A Propensity Score‐Matched Analysis of 4394 Patients

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Biodegradable‐polymer (BP) drug‐eluting stents (DES) were developed to mitigate potential late adverse events related to persistent durable polymers in durable‐polymer (DP) DES; however, contemporary long‐term real‐world comparative data remain limited. Aims We aimed to compare the 5‐year clinical outcomes of contemporary BP‐DES and
Yangyoun Lee, Hong‐Seok Lim, Kyoung‐Woo Seo, Hyoung‐Mo Yang, So‐Yeon Choi, Seung‐Jea Tahk, Myeong‐Ho Yoon   +6 more
wiley   +1 more source

Molecular basis of coronary artery disease-malignancy comorbidity: inflammation, immunometabolism, thrombosis, and cardio-oncology translation. [PDF]

Front Immunol
Li J, Zhao Y, Bai M.
europepmc   +1 more source

Galectin-3 and Coronary Artery Disease: An Inflammation-Based Approach. [PDF]

J Clin Med
Bora R, Tanrıverdi R, Fidancı ŞB, Toprak B, Gülüm C, Döven O, Tamer L.   +6 more
europepmc   +1 more source

Colchicine to prevent cardiovascular events in thoracic surgery patients with or without coronary artery disease: a secondary analysis. [PDF]

Open Heart
Razeghi G, Wang MK, Devereaux PJ, Popova E, Chan MT, Sessler DI, Landoni G, Warwas M, McIntyre WF, Ofori S, Balasubramanian K, Tandon V, Finley CJ, Shanthanna H, Tallada AG, Cata JP, Choi EK, Shah SU, Srinathan SK, Reimer C, McLean SR, Trujillo JC, Fleischmann E, Kabon B, Voltolini L, Cruz P, Maziak DE, Gutiérrez-Soriano L, Sigamani A, Amir M, Conen D, COP-AF investigators.   +31 more
europepmc   +1 more source